Sherwin-Williams (SHW) just delivered Q1 2026 results that came in ahead of expectations, reaffirmed its full year outlook and highlighted its new zero-VOC Emerald Symmetry paint as a sustainability-focused product launch.

The stock has softened in recent weeks, with a 7 day share price return of 5.39% and a 90 day share price return of an 11.58% decline. However, the 3 year total shareholder return is 41.41%, suggesting longer term holders are still ahead while near term momentum has faded.

If Sherwin-Williams has you thinking about where else steady compounding might come from, now is a good time to broaden your search and uncover 17 top founder-led companies

So with the stock off its highs despite solid Q1 numbers, steady buybacks and a new premium, sustainability-focused product, should you view Sherwin-Williams at about $318 as a fresh opportunity, or as a case where markets already price in future growth?

Most Popular Narrative: 18.1% Undervalued

At a last close of $318, the most followed narrative describes Sherwin-Williams as trading below an estimated fair value of about $388, framing a modest undervaluation built on specific growth and margin assumptions.

The updated analyst price target for Sherwin-Williams reflects a modest fair value adjustment of about $1. Analysts are factoring in a slightly lower discount rate and revenue growth assumptions, a small trim to expected profit margins, and a marginally higher future P/E multiple following recent earnings and mixed, but active, target revisions across the Street.

Want to see what underpins that gap between price and fair value? The narrative is based on measured revenue growth, firmer margins, and a premium earnings multiple that has to hold up over time.

Result: Fair Value of $388.14 (UNDERVALUED)

However, there are still clear pressure points, including prolonged weak demand in key end markets and supply chain inefficiencies that could squeeze margins and challenge that undervaluation story.

Another Way To Look At Valuation

That fair value of about $388 from the narrative sits alongside a simple P/E check. Sherwin-Williams trades on roughly 30x earnings, very similar to the US Chemicals industry at 30x and a touch below peer average at 30.9x, but above its fair ratio of 24.1x, which implies the valuation could drift closer to that lower level if sentiment cools.

For you, that raises a practical question: is the stock pricing in too much already, or do you think the business can keep justifying this kind of premium over its fair ratio and industry?

Next Steps

Given this mix of potential upside and clear areas of concern, it makes sense to act now and review the evidence for yourself using the 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If Sherwin-Williams has sharpened your interest in quality stocks, do not stop here. The wider market holds plenty of opportunities you will not want to miss.

• Target potential mispricings by scanning for companies that combine quality fundamentals with attractive valuations using the 49 high quality undervalued stocks.
• Strengthen your income stream by reviewing companies with higher yields and resilient payouts through the 13 dividend fortresses.
• Prioritise resilience by focusing on companies with lower risk characteristics and steadier profiles via the 72 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.